glp 1 gip dual agonist GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Dual GLP-1 / GIP Receptor

Have you noticed any muscle loss , and what steps are you taking to maintain strength and muscle mass

Jensen SBK, Janus C, Lundgren JR, et al

Abbreviations GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist T2DM: Type-2 diabetes mellitus DPP-4: Dipeptidyl peptidase 4 HbA1c: Hemoglobin A1c NASH: Non-alcoholic steatohepatitis NAFLD: Non-alcoholic fatty liver disease Camp: Cyclic adenosine monophosphate PKA: Protein kinase A EPAC: Exchange protein directly activated by cAMP PI3K: Phosphoinositide 3-kinase PYY: Peptide YY CCK: Cholecystokinin GLUT4: Glucose transporter type 4 mTORC1: Mammalian target of rapamycin complex 1 References Ahrn B (2015) Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes

Two people can weigh the exact same, yet one could have a much higher body fat percentage than the other, depending on how much muscle they carry

Cushing's disease and idiopathic intracranial hypertension: case report and review of underlying pathophysiological mechanisms